X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (15) 15
huntington's disease (12) 12
male (11) 11
female (9) 9
middle aged (9) 9
adult (8) 8
clinical neurology (8) 8
huntington disease - genetics (7) 7
age (6) 6
aged (6) 6
disease progression (6) 6
cohort studies (5) 5
huntingtons disease (5) 5
neurology (5) 5
neurosciences (5) 5
psychiatry (5) 5
age of onset (4) 4
genetic aspects (4) 4
genetics & heredity (4) 4
huntington disease - pathology (4) 4
polyglutamine (4) 4
severity of illness index (4) 4
trinucleotide repeat diseases (4) 4
abridged index medicus (3) 3
animals (3) 3
cancer (3) 3
case-control studies (3) 3
consortia (3) 3
development and progression (3) 3
genomes (3) 3
huntington disease - physiopathology (3) 3
life sciences (3) 3
longitudinal studies (3) 3
multidisciplinary sciences (3) 3
natural-history (3) 3
population (3) 3
proteins (3) 3
psychiatric status rating scales (3) 3
rats (3) 3
rats, sprague-dawley (3) 3
registry (3) 3
studies (3) 3
trinucleotide repeats (3) 3
alzheimer's disease (2) 2
amyotrophic lateral sclerosis - epidemiology (2) 2
amyotrophic lateral sclerosis - genetics (2) 2
analysis (2) 2
atrophy (2) 2
brain (2) 2
cag repeat (2) 2
cerebral engraftment (2) 2
cholinergic (2) 2
cognitive ability (2) 2
cohort (2) 2
comorbidity (2) 2
degeneration (2) 2
diagnosis (2) 2
disability evaluation (2) 2
disease (2) 2
dna-binding proteins - genetics (2) 2
frontotemporal dementia (2) 2
genetic predisposition to disease (2) 2
genetic research (2) 2
genetics (2) 2
genome-wide association study (2) 2
genome-wide association study - methods (2) 2
genomics (2) 2
group emsa-sg (2) 2
heterozygote (2) 2
huntingtin (2) 2
huntington disease (2) 2
huntington disease - complications (2) 2
huntington disease - epidemiology (2) 2
huntington's chorea (2) 2
huntingtons-disease (2) 2
in situ hybridization (2) 2
linear models (2) 2
magnetic resonance imaging (2) 2
medicine (2) 2
multiple system atrophy (2) 2
multiple system atrophy - complications (2) 2
muts homolog 3 protein (2) 2
natural history (2) 2
neurodegeneration (2) 2
neuropsychological tests (2) 2
onset (2) 2
pathogenesis (2) 2
phenotype (2) 2
polymorphism, single nucleotide (2) 2
prevalence (2) 2
principal component analysis (2) 2
progressive supranuclear palsy (2) 2
quality control (2) 2
quantile regression (2) 2
registries (2) 2
research article (2) 2
retrospective studies (2) 2
richardson-olszewski-syndrome (2) 2
risk-factors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by van Rheenen, Wouter and Shatunov, Aleksey and Dekker, Annelot M and McLaughlin, Russell L and Diekstra, Frank P and Pulit, Sara L and van der Spek, Rick A. A and Võsa, Urmo and de Jong, Simone and Robinson, Matthew R and Yang, Jian and Fogh, Isabella and van Doormaal, Perry Tc and Tazelaar, Gijs H. P and Koppers, Max and Blokhuis, Anna M and Sproviero, William and Jones, Ashley R and Kenna, Kevin P and van Eijk, Kristel R and Harschnitz, Oliver and Schellevis, Raymond D and Brands, William J and Medic, Jelena and Menelaou, Anoniki and Vajda, Alice and Ticozzi, Nicola and Lin, Kuang and Rogelj, Boris and Vrabec, Katarina and Ravnik-Glavač, Metka and Koritnik, Blaž and Zidar, Janez and Leonardis, Lea and Grošelj, Leja Dolenc and Millecamps, Stéphanie and Salachas, François and Meininger, Vincent and de Carvalho, Mamede and Pinto, Susana and Mora, Jesus S and Rojas-García, Ricardo and Polak, Meraida and Chanan, Siddharthan and Colville, Shuna and Swingler, Robert and Morrison, Karen E and Shaw, Pamela J and Hardy, John and Orrell, Richard W and Pittman, Alan and Sidle, Katie and Fratta, Pietro and Malaspina, Anea and Topp, Simon and Petri, Susanne and Abdulla, Susanne and pper, Carsten and Sendtner, Michael and Meyer, Thomas and Ophoff, Roel A and Staats, Kim A and Wiedau-Pazos, Martina and Lomen-Hoerth, Catherine and van Deerlin, Vivianna M and Trojanowski, John Q and Elman, Lauren and McCluskey, Leo and Basak, A. Nazli and Tunca, Ceren and Hamzeiy, Hamid and Parman, Yesim and Meitinger, Thomas and Lichtner, Peter and Radivojkov-Blagojevic, Milena and Anes, Christian R and Maurel, Cindy and Bensimon, Gilbert and Landwehrmeyer, Bernhard and Brice, Alexis and Payan, Christine A. M and Saker-Delye, Safaa and Dürr, Alexana and Wood, Nicholas W and Tittmann, Lukas and Lieb, Wolfgang and Franke, Ane and Rietschel, Marcella and Cichon, Sven and Nöthen, Markus M and Amouyel, Philippe and Tzourio, Christophe and Dartigues, Jean-François and Uitterlinden, Ane G and Rivadeneira, Fernando and Estrada, Karol and Hofman, Albert and Curtis, Charles and Blauw, Hylke M and van der Kooi, Anneke J and ... and PARALS Registry and FALS Sequencing Consortium and SLALOM Grp and SLAGEN Consortium and NNIPPS Study Grp and SLAP Registry and SLALOM Group and NNIPPS Study Group and Medicinska fakulteten and Institutionen för farmakologi och klinisk neurovetenskap and Klinisk neurovetenskap and Umeå universitet
Nature genetics, ISSN 1061-4036, 2016, Volume 48, Issue 9, pp. 1043 - 1048
Journal Article
Brain, ISSN 0006-8950, 2010, Volume 133, Issue 8, pp. 2382 - 2393
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 06/2014, Volume 23, Issue 11, pp. 2995 - 3007
Journal Article
Brain, ISSN 0006-8950, 1/2009, Volume 132, Issue 1, pp. 156 - 171
Parkinson plus diseases, comprising mainly progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are rare neurodegenerative conditions. We... 
Multiple system atrophy | Progressive supranuclear palsy | Randomized controlled trial | Riluzole | Natural history | MULTIPLE SYSTEM ATROPHY | RICHARDSON-OLSZEWSKI-SYNDROME | GROUP EMSA-SG | NINDS NEUROPATHOLOGIC CRITERIA | AMYOTROPHIC-LATERAL-SCLEROSIS | NATURAL-HISTORY | STRIATONIGRAL DEGENERATION | SPORADIC OLIVOPONTOCEREBELLAR ATROPHY | HUNTINGTONS-DISEASE | NEUROSCIENCES | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | Neuroprotective Agents - therapeutic use | Parkinson Disease, Secondary - etiology | Severity of Illness Index | Prognosis | Riluzole - adverse effects | Supranuclear Palsy, Progressive - drug therapy | Humans | Middle Aged | Male | Multiple System Atrophy - complications | Psychometrics | Treatment Outcome | Disease Progression | Supranuclear Palsy, Progressive - complications | Epidemiologic Methods | Riluzole - therapeutic use | Female | Multiple System Atrophy - drug therapy | Aged | Multiple System Atrophy - diagnosis | Neuroprotective Agents - adverse effects | Supranuclear Palsy, Progressive - diagnosis | Index Medicus | Abridged Index Medicus | Supranuclear Palsy, Progressive | Neuroprotective Agents | Parkinson Disease, Secondary | Life Sciences | Multiple System Atrophy | Santé publique et épidémiologie | multiple system atrophy | Original | natural history | riluzole | progressive supranuclear palsy | randomized controlled trial
Journal Article
by Oosterloo, Mayke and Bijlsma, Emilia K and van Kuijk, Sander MJ and Minkels, Floor and de Die-Smulders, Christine EM and Bachoud-Lévi, Anne-Catherine and Bentivoglio, Anna-Rita and Bentivoglio, Anna Rita and Biunno, Ida and Bonelli, Raphael M and Bronzova, Juliana and Burgunder, Jean-Marc and Dunnett, Stephen and Dunnett, Stephen B and Ferreira, Joaquim J and Frich, Jan C and Frich, Jan and Giuliano, Joe and Handley, Olivia J and Heiberg, Arvid and Illarioshkin, Sergey and Illmann, Torsten and Klempir, Jiri and Landwehrmeyer, Bernhard and Landwehrmeyer, G. Bernhard and Levey, Jamie and McLean, Tim and Nielsen, Jørgen and Nielsen, Jørgen E and Koivisto, Susana Pro and Päivärinta, Markku and Pålhagen, Sven and Quarrell, Oliver and Ramos-Arroyo, Maria and Ramos-Arroyo, Maria Antonia and Roos, Raymund A.C and Roos, Raymund AC and Roos, Peter and Saft, Carsten and Sebastián, Ana Rojo and Tabrizi, Sarah and Tabrizi, Sarah J and Vandenberghe, Wim and Verellen-Dumoulin, Christine and Uhrova, Tereza and Wahlström+, Jan and Zaremba, Jacek and (formerly Rödig, Verena Baake and Barth, Katrin and Garde, Monica Bascuñana and Becanovic, Kristina and Bernard, Tomáš and Betz, Sabrina and Bos, Reineke and Come, Adrien and Guedes, Leonor Correia and Callaghan, Jenny and Capodarca, Selene and Charpentier, Sébastien and Vieira da Silva, Wildson and Di Renzo, Martina and Ecker, Daniel and Finisterra, Ana Maria and Fullam, Ruth and Genoves, Camille and Gilling, Mette and Horta, Andrea and Hvalstedt, Carina and Held, Christine and Hussain, Hasina and Koppers, Kerstin and Lamanna, Claudia and Laurà, Matilde and Descals, Asunción Martínez and Martinez-Horta, Saul and Mestre, Tiago and Minster, Sara and Monza, Daniela and Münkel, Kristina and Mütze, Lisanne and Oehmen, Martin and Padieu, Helene and Paterski, Laurent and Peppa, Nadia and Rindal, Beate and Rogers, Dawn and Røren (formerly Heinonen), Niini and Salgueiro, Ana and Šašinková, Pavla and Seliverstov, Yury and Taylor, Catherine and Taylor, Cat and Taylor, Rachel and Taylor, Anne-Marie and Timewell, Erika and Townhill, Jenny and Cubillo, Patricia Trigo and van Walsem, Marleen R and van Walsem, Marleen and Witjes-Ané, Marie-Noelle and ... and EHDN's associate site in Singapore and REGISTRY Investigators of the European Huntington's Disease Network and Registry Steering committee and Language coordinators
Parkinsonism and Related Disorders, ISSN 1353-8020, 04/2019, Volume 61, pp. 101 - 105
The frequency of late-onset Huntington's disease (>59 years) is assumed to be low and the clinical course milder. However, previous literature on late-onset... 
Age of onset | Huntington's disease | Late-onset Huntington's disease | CLINICAL NEUROLOGY | AGE | FEATURES | Genetic research
Journal Article